These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 9885941)

  • 1. Protracted exposure radiosensitization of experimental human malignant glioma.
    Williams JA; Williams JR; Yuan X; Dillehay LE
    Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X; Tabassi K; Williams JA
    Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
    Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
    Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Yuan X; Dillehay LE; Williams JR; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
    Mitchell CR; Joiner MC
    Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
    Pinel S; Barberi-Heyob M; Cohen-Jonathan E; Merlin JL; Delmas C; Plenat F; Chastagner P
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):250-9. PubMed ID: 15093922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
    Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
    Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
    Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
    Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.
    Verhoeff JJ; Stalpers LJ; Coumou AW; Koedooder K; Lavini C; Van Noorden CJ; Haveman J; Vandertop WP; van Furth WR
    Radiat Oncol; 2007 Sep; 2():38. PubMed ID: 17897452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S; Trisler K; Wessels BW; Knox SJ
    Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
    Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
    J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioresistant subline of human glioma cell line MGR2R induced by repeated high dose X-ray irradiation].
    Cheng JJ; Hu Z; Xia YF; Chen ZP
    Ai Zheng; 2006 Jan; 25(1):45-50. PubMed ID: 16405748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The decreased influence of overall treatment time on the response of human breast tumor xenografts following prolongation of the potential doubling time (Tpot).
    Sarkaria JN; Fowler JF; Lindstrom MJ; Jordan VC; Mulcahy RT
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):833-40. PubMed ID: 7860396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
    Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
    J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV; Bloomer WD; Hollingshead MG
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.